Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Cancer Metastasis Review

• Publication date

  2021-05-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10555-021-09970-6PMID 33959849PMCID PMC9863248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absence of CCR2 reduces spontaneous intestinal tumorigenesis in the ApcMin/+ mouse model

  2021cited by this paper
• Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy

  2020cited by this paper
• Tumor angiogenesis

  2020cited by this paper
• CXCR2 signaling promotes secretory cancer‐associated fibroblasts in pancreatic ductal adenocarcinoma

  2020cited by this paper
• Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma

  2020cited by this paper
• The CCL20-CCR6 Axis in Cancer Progression

  2020cited by this paper
• Antigens of Mycobacterium tuberculosis Stimulate CXCR6+ Natural Killer Cells

  2020cited by this paper
• Atypical chemokine receptors in tumor cell growth and metastasis.

  2020cited by this paper
• CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway

  2020cited by this paper
• Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression.

  2020cited by this paper
• Neutrophil: A New Player in Metastatic Cancers

  2020cited by this paper
• Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy

  2020cited by this paper
• CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4

  2020cited by this paper
• The CCL5/CCR5 Axis in Cancer Progression

  2020cited by this paper
• Breast Cancer Cell–Neutrophil Interactions Enhance Neutrophil Survival and Pro-Tumorigenic Activities

  2020cited by this paper
• Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers

  2020cited by this paper
• Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer

  2020cited by this paper
• Leukotrienes in Tumor-Associated Inflammation

  2020cited by this paper
• CX3CL1 Signaling in the Tumor Microenvironment.

  2020cited by this paper
• High CXCR3 on Leukemic Cells Distinguishes IgHVmut from IgHVunmut in Chronic Lymphocytic Leukemia: Evidence from CD5high and CD5low Clones

  2020cited by this paper
• Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

  2019cited by this paper
• Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer.

  2019cited by this paper
• Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression

  2019cited by this paper
• Support of Tumor Endothelial Cells by Chemokine Receptors

  2019cited by this paper
• Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo

  2019cited by this paper
• CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

  2019cited by this paper
• Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy

  2019cited by this paper
• Mechanisms and Implications of Metabolic Heterogeneity in Cancer.

  2019cited by this paper
• Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy

  2019cited by this paper
• CXCR3 Identifies Human Naive CD8+ T Cells with Enhanced Effector Differentiation Potential

  2019cited by this paper
• Interleukin17-CXCR2 axis facilitates breast cancer progression by up-regulating neutrophil recruitment.

  2019cited by this paper
• Cellular Senescence: Aging, Cancer, and Injury.

  2019cited by this paper
• Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy

  2019cited by this paper
• The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells

  2019cited by this paper
• Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.

  2019cited by this paper
• Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance.

  2019cited by this paper
• Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions.

  2019cited by this paper
• Cellular senescence in cancer

  2019cited by this paper
• Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum

  2019cited by this paper
• The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis

  2019cited by this paper
• Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients

  2019cited by this paper
• Metastasis Organotropism: Redefining the Congenial Soil.

  2019cited by this paper
• The role of CXCR6 deficient Natural Killer T- and CD4 + T cells in hepatocarcinogenesis.

  2019cited by this paper
• Tumor-Associated Neutrophils in Cancer: Going Pro

  2019cited by this paper
• The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells

  2019cited by this paper
• Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients

  2019cited by this paper
• Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma

  2019cited by this paper
• Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.

  2019cited by this paper
• Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism via the CXCL10-CXCR3 Signaling Axis.

  2019cited by this paper
• Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy

  2019cited by this paper
• CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis

  2019cited by this paper
• Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

  2019cited by this paper
• Hallmarks of Cellular Senescence.

  2018cited by this paper
• Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy

  2018cited by this paper
• Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.

  2018cited by this paper
• The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling

  2018cited by this paper
• A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models

  2018cited by this paper
• Cancer stemness, intratumoral heterogeneity, and immune response across cancers

  2018cited by this paper
• Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.

  2018cited by this paper
• Mogamulizumab Tops Standard of Care for CTCL.

  2018cited by this paper
• CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2.

  2018cited by this paper
• Chemokines: the past, the present and the future

  2018cited by this paper
• CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion.

  2018cited by this paper
• Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization

  2018cited by this paper
• CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes.

  2018cited by this paper
• A guide to chemokines and their receptors

  2018influential reference
• The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells

  2018cited by this paper
• AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression

  2018cited by this paper
• Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.

  2018cited by this paper
• CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation

  2018cited by this paper
• CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway

  2018cited by this paper
• Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

  2018cited by this paper
• Metastatic niche functions and therapeutic opportunities

  2018cited by this paper
• Retracted: Role of CXCL12–CXCR4 axis in ovarian cancer metastasis and CXCL12–CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro

  2018cited by this paper
• CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease

  2018cited by this paper
• Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling

  2018cited by this paper
• Cancer cell CCR2 orchestrates suppression of the adaptive immune response

  2018cited by this paper
• Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.

  2018cited by this paper
• Genetic insights into the morass of metastatic heterogeneity

  2018cited by this paper
• Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer

  2018cited by this paper
• CXCR7 Targeting and Its Major Disease Relevance

  2018cited by this paper
• Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands

  2018cited by this paper
• Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors

  2018influential reference
• An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition

  2017cited by this paper
• A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer

  2017cited by this paper
• CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro

  2017cited by this paper
• A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies.

  2017cited by this paper
• CXCR1/2 Chemokine Network Regulates Melanoma Resistance to Chemotherapies Mediated by NF-κB.

  2017cited by this paper
• Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer

  2017cited by this paper
• 750PPhase Ib study of PF-04136309 (an oral CCR2 inhibitor) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic adenocarcinoma

  2017cited by this paper
• Inflammatory cytokine IL-8/CXCL8 promotes tumour escape from hepatocyte-induced dormancy

  2017cited by this paper
• Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis

  2017cited by this paper
• CXCR5+ CD8+ T cells potently infiltrate pancreatic tumors and present high functionality

  2017cited by this paper
• Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

  2017cited by this paper
• The yin and yang of leukotriene B4 mediated inflammation in cancer.

  2017cited by this paper
• Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T‐cell malignancies

  2017cited by this paper
• CCR2 blockade alters the tumor microenvironment immune infiltrate and enhances anti-tumor activity in ovarian cancer

  2017cited by this paper
• CD8+ T Cells Orchestrate pDC‐XCR1+ Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming

  2017cited by this paper
• Emerging Biological Principles of Metastasis.

  2017cited by this paper
• CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer.

  2017cited by this paper

• Interpreting cancer genetics through a two-step "evolutionary cascade hypothesis": bridging neutral and selective perspectives.

  2026cites this paper
• PLS3 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Head and Neck Squamous Cell Carcinoma

  2025cites this paper
• Epigenetic regulation of the tumor microenvironment in lung cancer: mechanism insights and therapeutic prospects

  2025cites this paper
• Single-cell multi-omics in biliary tract cancers: decoding heterogeneity, microenvironment, and treatment strategies

  2025cites this paper
• Fighting cancer smarter: Using hydrogel delivery systems to target chemokines.

  2025cites this paper
• The role of inflammation in colorectal Cancer and the preventive potential of natural compounds

  2025cites this paper
• A rare case report of insular metastatic from sarcoma with successful long term surgical and oncological management

  2025cites this paper
• Tumor-Associated Macrophages as Key Modulators of Disease Progression in Diffuse Large B-Cell Lymphoma

  2025cites this paper
• E2F expression profiling-based subtypes in head and neck squamous cell carcinoma: clinical relevance, prognostic implications, and personalized therapy

  2025cites this paper
• The Role of Long Non-Coding RNAs in Modulating the Immune Microenvironment of Triple-Negative Breast Cancer: Mechanistic Insights and Therapeutic Potential

  2025cites this paper
• Yiqi Huayu Jiedu Decoction reduces colorectal cancer liver metastasis by promoting N1 neutrophil chemotaxis

  2025cites this paper
• CCL20 in the tumor microenvironment: implications for cancer progression and therapeutic approaches

  2025cites this paper
• The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases

  2025cites this paper
• Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients

  2025cites this paper
• Inflammatory response in traumatic brain and spinal cord injury: The role of XCL1‐XCR1 axis and T cells

  2024cites this paper
• Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma

  2024cites this paper
• Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer

  2024cites this paper
• Expression of PTGS2 along with genes regulating VEGF signalling pathway and association with high‐risk factors in locally advanced oral squamous cell carcinoma

  2024cites this paper
• Chemokine systems in oncology: From microenvironment modulation to nanocarrier innovations.

  2024cites this paper
• IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside.

  2024cites this paper
• Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

  2024cites this paper
• Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance

  2024cites this paper
• Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets.

  2024cites this paper
• Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer patients undergoing neoadjuvant chemotherapy: A systematic review and meta-analysis

  2024cites this paper
• Molecular signature of immune-related new survival predictions for subtype of renal cell carcinomas

  2024cites this paper
• Preclinical trial of targeting the Hic-5-mediated pathway to prevent the progression of hepatocellular carcinoma.

  2023cites this paper
• Potential molecular mechanisms of myrtenal against colon cancer: A systematic review

  2023cites this paper
• Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer.

  2023cites this paper
• New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine

  2023influential citation
• The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis

  2023cites this paper
• Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation.

  2022cites this paper
• Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies

  2022cites this paper
• Zebrafish—An Optimal Model in Experimental Oncology

  2022cites this paper
• Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact.

  2022cites this paper
• Characterization of the Prognostic Values of CXCL Family in Epstein–Barr Virus Associated Gastric Cancer

  2022cites this paper
• [MiR-372-5p regulates PI3K/AKT/CXCL12 signaling pathway by targeting PTEN to promote colorectal cancer cell metastasis].

  2022cites this paper
• Signaling pathways governing glioma cancer stem cells behavior.

  2022cites this paper
• Extracellular vesicles promotes liver metastasis of lung cancer by ALAHM increasing hepatocellular secretion of HGF

  2022cites this paper
• Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence

  2022cites this paper
• Chemokines and Cytokines: Axis and Allies in Prostate Cancer Pathogenesis.

  2022cites this paper
• Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma.

  2022cites this paper
• The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors

  2022cites this paper
• Chemokines in Triple-Negative Breast Cancer Heterogeneity: New Challenges for Clinical Implications.

  2022cites this paper
• Chemokine Clouding and Liver Cancer Heterogeneity: Does it Impact Clinical Outcomes?

  2022cites this paper
• Molecular Dynamics Insights into the Selectivity Toward CXCR1 and CXCR2 Antagonists

  2022cites this paper
• Rethinking the Chemokine Cascade in Brain Metastasis: Preventive and Therapeutic Implications.

  2021cites this paper
• Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician

  2021cites this paper